Award,contract · Public Contracts Scotland
Enzyme Replacement Therapy Medicines
Part of Enzyme Replacement Therapy Medicines.
Supply of Enzyme Replacement Therapy Medicines (a-d) to NHS Scotland: - NP92624(a) Laronidase 500units/5ml solution for infusion vials 1 vial (Aldurazyme®) - NP92624(b) Imiglucerase 400unit powder for solution for infusion vials 1 vial (Cerezyme®) - NP92624(c) Agalsidase beta 35mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(c) Agalsidase beta 5mg powder for solution for infusion vials 1 vial (Fabrazyme®) - NP92624(d) Alglucosidase alfa 50mg powder for solution for infusion vials 1 vial (Myozyme®)
- Procurement
- Enzyme Replacement Therapy Medicines
- Published
- 15 Aug 2024
- Status
- complete
- CPV
- 33600000
- Tender period
- —
Awards
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award,contract published via Public Contracts Scotland on 15 Aug 2024.
Which procurement does this notice belong to?
It is part of "Enzyme Replacement Therapy Medicines", published by City of Glasgow College.
Has this notice resulted in an award?
1 award is recorded on this notice, including to Softcat.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable